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AB S T R A CT  
Antimicrobial drug resistance is increasingly becoming an important global problem.  Among the major 
causes for concern is drug resistant Streptococcus pneumoniae and Salmonella typhi, which have become 
resistant to at least one antibiotic.  This challenge has lead scientists to investigate plants as potential 
sources of antimicrobial agents since they have been used to treat diseases long before the discovery 
of antibiotics.  In Zimbabwe, typhoid is a leading cause of mortality and morbidity due to poor 
sanitation and poor treatment regimes.  Traditionalists are using Melia azedarach leaves for the treatment 
of diarrhea, a typhoid symptom.  Thus, this study focused on validating the use of M. azedarach leaves 
for medicinal purposes by determining their antibacterial activity against S. pneumoniae and S.typhi, the 
causative agent of typhoid fever.  Melia azedarach leaf constituents were extracted using ethanol, 
ethylacetate, hexane, dichloromethane and methanol.  Their antibacterial activities were assessed using 
the agar disk diffusion, minimum inhibitory concentration (MIC) and minimum bactericidal 
concentration (MBC) assays.  Haemolysis assay was carried out to determine the toxicity of the potent 
extracts.  The ethanol and hexane extracts showed antibacterial activity against S. typhi whilst 
dichloromethane and hexane extracts showed antibacterial activity against S. pneumoniae.  Minimum 
inhibitory concentrations for ethanol and hexane against S. typhi were < 1 µg/ml and 15.6 µg/ml 
respectively, whilst their minimum bactericidal concentrations were 31.25 µg/ml and 250 µg/ml.  The 
MICs for dichloromethane and hexane extracts against S. pneumoniae were 31.25 µg/ml and 62.5 µg/ml 
respectively, whilst their MBCs were 31.25 µg/ml and 125 µg/ml.  The extracts ethanol, hexane and 
dichloromethane had haemolytic activity of 63 %, 62 % and 59 % respectively.  Therefore, these results 
validate the use of M. azedarach leaves for medicinal purposes.  However, these leaves may be toxic to 
human consumption, thus there is need for further investigation on their toxicity in vivo.  
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1 Introduction 
Most cases of death are due to infectious diseases, 
particularly in low-income countries [1]. A 
number of antibiotics have been introduced to 
treat these diseases, accounting to the fall in the 
number of deaths [2].  However, disease causing 
agents are still a threat to society due to resistance 
of these causative agents to the antibiotics [3].  
The overuse and misuse of these antibiotics has 
led to the resistance of these strains to treatment 
[4].  Typhoid fever, being an important infectious 
disease, has received considerable control efforts 
at national, regional and district levels with the aid 
of World Health Organisation. However, despite 
all the efforts the disease continues to persist 
leading to significant morbidity and mortality 
rates due to antibiotic resistance.  Typhoid fever 
is caused by salmonella typhi, which has emerged 
and become prevalent in typhoid outbreak areas, 
suggesting that the mortality rate will likely to 
increase in the future if new treatment options are 
not developed [5; 6].  Typhoid fever is a life-
threatening infectious disease that is common in 
Zimbabwe especially in the summer seasons 
according to the City of Harare council report of 
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2011.  The leading cause of the outbreak of the 
disease is due to the inadequate sanitary 
provisions for everyone in the country.  Water 
supplies are not sufficient enough and hence, 
individuals tend to use other water sources like 
unprotected wells and river water, contaminated 
boreholes [7].  The sewage reticulation systems 
installed in the colonial era have not been 
improved as they were installed to accommodate 
a low population number.  These systems are 
failing due to the growing populations leading to 
sewage spillage and raw sewage flowing in suburb 
streets.  Substandard waste removal systems are 
also a threat to the spread of the disease.  
According to the UNICEF Zimbabwe Mid-Year 
Situation Report, from January 2017-June 2017, a 
total of 2,415 suspected typhoid cases with six 
typhoid related deaths were reported, out of 
which 79 were laboratory confirmed.   
On October 16, 2017, the Harare City Health 
Department (HCHD) identified a cluster of 17 
suspected typhoid cases in residents of Harare’s 
Mbare suburb.  As of 24 February 2018, more 
clusters were detected in Harare’s western 
suburbs, including Kuwadzana, where high rates 
of ciprofloxacin-resistant Typhi were identified. 
A total of 3,187 suspected and 191 confirmed 
cases were identified with no reported deaths 
among confirmed cases. Among suspected cases, 
1,696 (53%) patients were male, and median age 
was 17 years (range = 1 month–90 years). [8] 
The standardized collection and analysis of 
clinical and laboratory information during an 
outbreak in which an unusual regional antibiotic 
resistance pattern featured prominently 
prompted public health officials to recommend 
third-generation cephalosporins as first-line 
treatment for patients residing in areas with high 
rates of ciprofloxacin resistance [9] 
On the other hand, the incidence of antimicrobial 
resistance in the leading causative agent of 
pneumococcal infections, S. pneumoniae is a major 
public health concern worldwide.  Streptococcus 
pneumoniae has become resistant to most 
commonly prescribed antibiotics including β 
lactams and macrolides by acquiring genes from 
closely related species residing in the same 
environment resulting in transformation.  By this 
process, different strains of S. pneumoniae have 
become resistant to most classes of antibiotics 
[10].  The lethality of pneumococcal infection 
arises as a complication of immunosuppression 
due to the presence of a debilitating disease.  
Streptococcus pneumoniae is the leading cause of 
bacterial meningitis, pneumonia and sepsis in 
children and the elderly.  Haematologic cancers, 
anatomic asplenia, acquired immune deficiency 
like HIV infections and congenital immune 
deficiency like SCID as well as 
immunosuppressive therapy (including 
chemotherapy) are risk factors for infections with 
invasive S. pneumoniae. 
Lately, there has been an interest in traditional 
medicines driven by interest in complementary 
medicine.  Melia azedarach is one of the plant 
species that has been used in the history of herbal 
medicines.  The tree is native in south of Asia and 
has been naturalized in Zimbabwe and most parts 
of the world including America [11].  In 
Zimbabwe, it is known as mukina or musiringa, but 
in English it is known as china berry tree or 
Indian lilac.  The tree belongs to the mahogany 
family, Meliaceae.  Melia azedarach has been used 
traditionally to treat symptoms associated with 
typhoid infection such as headache, abdominal 
discomfort, vomiting, diarrhea, cough, or 
constipation, fever and other infections.  
Scientific and clinical research has proven that 
extracts of the tree have antimicrobial, anticancer, 
antioxidant, male contraceptive, antipyretic, 
antiplasmodial, antiulcer as well as analgesic 
properties and have been used to make pesticides 
and insecticides [12; 13].  
Therefore, this study seeks to justify the 
antibacterial activity of Melia azedarach leaf extract 
being used traditionally to treat stomach 
disorders and symptoms of bacterial meningitis. 
2 Materials and Methods 
 Collection of plant leaves 
Identification and authentication of the plant was 
done at Harare Botanical Gardens with the help 
of Mr Chris Chapano (Botanist).  Mature fresh 
green leaves of M. azedarach were collected at the 
University of Zimbabwe campus opposite the 
Science lecture theater in August 2017.  Collected 
leaves were dried in open air, ground to a fine 
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powder and stored in airtight containers at room 
temperature prior to antimicrobial assays. 
 Preparation of plant extracts 
The ground powder of the leaves was divided 
into 5 equal portions and to each portion, solvent 
was added and mixed thoroughly.  The solvents 
used were dichloromethane, ethyl acetate, 
ethanol, hexane and methanol.  Extraction was 
carried out for three days with agar disk 
diffusion assay was used to determine the 
susceptibility of the plant regular mixing of 
contents.  The mixture was filtered using 
Whatman No 1 filter paper and cotton wool and 
the filtrate was collected.  The solvents were then 
allowed to evaporate under room temperature 
and pressure.  Dried extracts were then stored at 
4 ºC until use.  
 Test organisms 
Salmonella typhi and Streptococcus pneumoniae 
strains were provided by Prof. Mukanganyama 
from the Department of Biochemistry at the 
University of Zimbabwe, Zimbabwe. Cells 
were resuscitated separately by culturing them 
in nutrient broth at 37 °C and 150rpm.  The 
bacteria were then streaked on a nutrient agar 
plates to determine if the cultures were not 
contaminated.  Presence of different colonies 
after incubation overnight at 37°C would mean 
that another bacterium could have 
contaminated the strains.  The nutrient agar 
plates and the broth cultures were stored in the 
fridge at 4°C. 
 Disc diffusion assay 
The extracts against S. typhi and S. pneumoniae.  
Sterile filter paper discs (6 mm) were 
impregnated with 500µg of crude extract of each 
solvent.  The S. typhi and S. pneumoniae inoculums 
were prepared to a final concentration of 106 
CFU/ml by using 0.5M McFarland’s standard 
and poured in agar plates.  The impregnated discs 
were then loaded onto the agar plates and 
incubated in the fridge at 4°C for 2 hours (pre-
diffusion time).  After incubation, the bacteria 
were allowed to grow at 37°C overnight.  Pure 
solvents used for extraction were used as 
controls. The results were recorded by measuring 
the zones of growth inhibition.  Clear inhibition 
zones around discs indicated the presence of 
antimicrobial activity. 
 MTT assay 
The MTT assay was carried out to determine 
the minimum concentration of the potent 
plant extracts that had visible growth 
inhibitory activity against S. typhi and S. 
pneumoniae. Various concentrations of the 
plant extracts were prepared in a 96 well 
ELISA plate, from 500 µg/ml to 0.1µg/ml 
by two fold dilution.  A volume 100 µl of the 
standardized inoculums 10 6 CFU/ml were 
added to each dilution well containing a 
different plant concentration. The plate was 
then incubated overnight at 37°C.  Growth 
of the bacterial cells was observed by 
turbidity, however because it was not 
conclusive, 25 µl of 2 mg/ml of MTT (3-(4, 
5-Dimethylthiazol-2-yl)-2, 5- 
Diphenyltetrazolium Bromide) was added.  
MTT assesses the viability of live bacterial 
cells through a reduction reaction of the 
yellow tetrazole to give purple formazan with 
the intensity depending on the concentration 
of the bacterial cells present.  This reaction is 
catalaysed by oxidoreductase enzymes in 
viable cells. Thus, the intensity was measured 
using a spectrophotometer at 540 nm.  The 
lowest concentration of the extract that 
inhibits growth was recorded as the MIC  
 Minimum Bactericidal Concentration 
determinations 
Minimum bactericidal concentration was 
determined by re-culturing cells from wells that 
had no viable cells present from the MTT assay.  
Cells were streaked onto nutrient agar and 
incubated at 37°C overnight.  Growth of the 
bacteria on agar shows presence of viable cells in 
the well.  The lowest extract concentration which 
showed no growth of bacteria on the media is the 
MBC value.  
 Haemolytic assay 
 A volume of 5 ml of sheep blood in EDTA was 
centrifuged at 1000 rpm and 4 °C for 10 minutes 
[14].  The supernatant and buffy coat layer were 
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carefully discarded. The pellet collected was 
washed 3 times with phosphate buffered saline 
(PBS).   The erythrocyte pellet (100 µl) was 
diluted using 900µl of PBS and 50 µl of the 
diluted sample was mixed with 100µl of plant 
extract.  This was done for plants that showed 
antibacterial activity against both S. typhi and S. 
pneumoniae, at their MIC values.  For the positive 
control, 50µl of diluted erythrocytes were mixed 
with 10 % Sodium Dodecyl Sulphate (SDS). The 
negative control had 100µl of PBS. The contents 
were then incubated at 37°C for 60 minutes.  
After incubation 850µl of PBS were added to 
each reaction vessel and thoroughly mixed.  The 
tubes were centrifuged at 300 rpm for 3 minutes 
and the supernatant was put into respective wells 
of a 96 well ELISA plate.  The absorbance was 
read at 545nm.  Percentage lysis was determined 
using the positive control as 100 % lysis. 
Percentage haemolysis of the extracts was 
calculated by the formula: 
(Absorbance of red blood cells with plant extract ÷ 
Absorbance of red blood cells with SDS) ×100% 
 Statistical analysis 
Data analysis was done by Graph Pad Prism 5 to 
obtain the standard deviation of the inhibition 
zones of the extracts and streptomycin obtained 
from the agar disk diffusion test.  Graph Pad 
Prism 5 was used in calculating the standard 
deviation for the haemolytic assay absorbances. 
3 Results 
 Inhibition of growth of S. typhi and S. 
pheumoniae growth by M. azedarach 
extracts 
The effects M. azedarach extracts on the growth of 
S. typhi and S. pheumoniae is shown by zones of 
inhibition in Table 3.1.  The hexane extract 
inhibited both the bacteria species with S. 
phemoniae being inhibited the most.  The ethanol 
extract inhibited S. typhi only and 
dichloromethane inhibited S. pheumoniae only.  
The methanol and ethyl acetate extracts did not 
show any inhibitory activity against these two 
bacterial species.  Although both plant extracts 
inhibited the bacterial species, the effects were 
less than that of streptomycin, a known 
antibiotic, except for hexane extract which 
showed an inhibition zone of 17 ± 4 mm against 
S. typhi whilst streptomycin had 12 ± 2 mm.   
Table 3.1: Susceptibility of S. typhi and S. 
pheumoniae to 500µg of plant extract. 
Plant extract  Inhibition zone (mm) 
 S. pheumoniae S. typhi 
Dichlomethane 9.6±0.78 6 
Ethyl Acetate 6 6 
Ethanol 6 10 ± 3 
Hexane 11.7 ± 2 17 ± 4 
Methanol 6 6 
Streptomycin 22.3 ± 4.4  12 ± 2 
Antibacterial activity of M. azedarach extracts. The 
commercial drug streptomycin was used as the 
control for the experiment. Methanol, ethanol 
and ethyl acetate extracts did not inhibit the 
growth of bacteria on the agar plates therefore 
there was no zone of inhibition. The value 6 is 
the diameter of the disc. Values are means + SD 
for N=2 incubations.   
 MIC and MBC determination  
The ethanol and hexane extracts of M. azedarach 
were found to have MICs of <1µg/ml and 15.6 
µg/ml against S. typhi respectively and the MBC 
values were found to be 31.25 and 250 µg/ml 
(Table 3.2). Dichloromethane and hexane 
extracts were also found to have the MIC values 
of 31.25 and 62.5 µg/ml respectively against S. 
pheumoniae and the MBCs values were 31.25 and 
125 µg/ml.  The positive control, streptomycin 
had an MIC of 7.8 against both species but the 
MBC value was 15.6 against S. pheumoniae and 500 
against S. typhi.     
Table 3.2:  MIC and MBC determination 
Plant extract MIC (µg/ml) MBC (µg/ml) 
 S. 
pheum
oniae 
S. 
typhi 
S. 
pheumoni
ae 
S. 
typhi 
Dichloromethane   31.25 - 31.25 - 
Ethanol - <1 - 31.25 
Hexane 62.5 15.6 125 250 
Streptomycin 7.8  7.8 15.6 500 
MIC was determined by MTT assay where 
concentrations of the plant extracts were 
diluted from 500 µg/ml to 1 µg /ml. MBC was 
51 
 
 
 ISSN: 2456-7132  
Available online at Journals.aijr.in 
Mwale et al., Int. Ann. Sci.; Vol. 8, Issue 1, pp: 47-53, 2020 
determined by reculturing cells from wells that 
did not show viability by MTT assay. The 
lowest concentration that showed growth was 
regarded as the MBC. Values are means + SD 
for N=2 incubations. 
 Toxicity effects  
Haemolysis assay was carried out to assess the 
effect of the active extracts on mammalian 
(sheep) red blood cells.  The haemoglobin 
released by red blood cells when they lyse was 
measured at 545nm against a positive control of 
10 % SDS.  The MIC of plant extracts obtained 
against both bacterial species was used to 
determine haemolytic activity.  Table 3.3 shows 
that all tested extracts had haemolytic activity.  
Ethanol had 62.9 ± 0.4 %, hexane had 61.8 ± 
1.8 % and dichloromethane had 58.7%.  
Table 3.3: Haemolytic activity of plant extracts 
that showed antibacterial activity 
Plant extract % haemolysis 
Dichlomethane 58.7 
62.9 ± 0.4 
61.8 ± 1.8 
100 
Ethanol 
Hexane 
SDS 
The MICs of plant extracts obtained against both 
extracts were used to determine haemolysis 
activity.  Values are means + SD for N=2 
incubations 
4 Discussion 
The combination of poor water quality and 
sanitation and urban overcrowding continues to 
be a persistent driver of seasonal outbreaks of 
waterborne diseases in Harare.  Therefore, 
comprehensive measures are needed to improve 
the water treatment and delivery 
system in Harare as well as treatment of typhoid.  
One such measure includes development of new 
antibacterial agents for the treatment of typhoid.  
Thus, in this study, the antibacterial activity of M. 
azedarch leaf crude extracts was assessed by 
measuring inhibition zones (Table 3.1).  
Inhibition growth of the highest zone was that of 
the hexane extract with 17 mm growth inhibition 
zone, followed by that of ethanol with 10 mm, 
against S. typhi.  The extracts of dichloromethane, 
ethyl acetate and methanol showed no 
antibacterial activity at 500 µg against S. typhi by 
the disk difussion assay.  The probability that 
these solvents failed to extract compounds with 
antibacterial activity is high.  Dichlorometahne 
and hexane extracts showed antibacterial activity 
against S. pheumoniae with average zone of 10 mm 
and 12mm respectively.  Phytochemicals that can 
be extracted with ethanol, hexane and 
dichloromethane are mostly terpenes and 
flavonoids, glycosides, alkaloids, saponnins, 
tannins, tritepenoids and steroids [15].  
Flavonoids have a wide range of pharmacological 
and biological functions including anticancer, 
anti-inflammatory, antioxidant, anti-allergic and 
antibacterial properties. Different 
phytochemicals in the class of flavonoids affect 
bacterial growth in different ways.  Studies done 
using Proteus vulgaris and S aureus, E.coli and S. 
typhimurium show that flavonoids strongly inhibit 
DNA and RNA synthesis [16].  Terpenes have 
antimicrobial activity against a wide variety of 
microorganisms including fungi, gram-positive 
and gram-negative bacteria. The most active 
terpenoid class of phytochemicals found in M. 
azedarach leaf include azedirachitn, nimbin and 
nimbidine.  Research has reported that nimbin 
has antibacterial, antifungal, anti-inflamatory, 
antipyretic, antiseptic and antihistamine 
properties [17].    Terpenoids are known to inhibit 
respiration as well as alter ion transport processes 
[18].  Alkaloids also have been shown to have 
growth inhibition mechanisms. These 
phytochemicals may be responsible for inhibiting 
growth in the two bacterial species investigated in 
this study.  
The minimum inhibitory concentration (MIC) 
was used to determine the potency of extracts 
that were found to have antibacterial activity 
using the disk diffusion assay.  The assay was 
done using the 3-(4, 5-dimethylthiozol-2-yl)-2-5-
diphenyltetrazolium bromide assay (MTT assay). 
The MTT assay is used to assess the presence of 
metabolic activity in cells. The assay quantifies 
cellular oxidoreductases that depend on 
NAD(P)H to reflect the amount of viable cells 
present in the assay.  MTT is yellow in colour and 
is reduced by mitochondrial succinate 
dehydrogenase to an insoluble formazan product 
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which is purple in colour.  This reaction occurs 
only in cells that are metabolically active.  The 
intensity of the purple colour is a measure of the 
level of activity and amount of viable cells in the 
assay.  The concentration of the extracts 
decreased across the plate inorder to determine 
the lowest concentration of the extract at which 
bacteria growth is inhibited [19].  The wells 
whose colour changed to purple had live cells 
whilst those that remained yellow had 
metabolically inactive cells.  When cells cease to 
be metabolically active they die.  Therefore, using 
the MTT assay, the ethanolic extract had an MIC 
of <1 µg/ml, while the hexane extract was 15.6 
µg/ml against S. typhi. Inoculumns were 
recultured to obtain the MBC values which were 
found to be 31.5 µg/ml and 250 µg/ml 
respectively.  These two extracts were 
bacteriostatic at low concentrations and 
bactericidal at high concentrations.  The MIC 
values of dichloromethane and hexane against S. 
pheumoniae were 31.25 µg/ml and 62.5 µg/ml   
respectively.  
Haemolytic assay was performed for the extracts 
that exhibited antibacterial activity at their MIC 
values.  SDS (10 %) was used as a positive 
control because it causes 100 % haemolysis of 
red blood cells.  Haemolytic activity of the all the 
plant extracts was concentration-dependant, at 
higher concentrations, the extracts showed high 
haemolytic activity. Haemolytic activity of 62.93 
± 0.4 % for ethanol and 61.86 ± 1.8 % for 
hexane extract, 58.7% for dichloromethane 
extract was observed.  The presence of 
saponnins in the extracts could be the cause for 
the haemolytic activity.  Saponnins tend to react 
with the lipids in the phospholipid bilayer 
causing increased permeability of the 
erythrocytes thereby allowing influx of other 
molecules eventually leading to the cell bursting, 
releasing haemoglobin. Also, the plant fruits 
according to recent studies, proved that they are 
poisonous for human consumption because they 
contain meliatoxins [11], which might as well 
support the evidence that the leaves have 
haemolytic activity. However further studies 
have to be done to investigate the actual 
component in the leaf extracts that exhibits anti-
bacterial activity and check for its toxicity rather 
than testing the crude extracts which might have 
constituents that maybe have no anti-bacterial 
activity and yet toxic. 
5 Conclusion 
Salmonella typhi and Streptococcus pneumoniae have 
increasingly become multi drug resistant by 
developing various mechanisms to defend against 
the effects of the drugs. The ineffectiveness of 
some antibiotics such as ciprofloxacin in the 
treatment of typhoid, and penicillin, macrolides 
and cephalosporins in the treatment of 
pneumococci infections has led to the 
investigations of antibacterial properties of 
phytocompounds found in plants. The results of 
this study validates the use of M. azedarach as a 
medicinal plant, as the ethanolic and hexane 
extracts of M. azedarach leaves were found to have 
the antibacterial activity against Salmonella typhi 
whilst  dichloromethane and hexane were found 
to have antibacterial activity against S. pheumoniae. 
However, the potent plant extracts were found to 
be toxic in vitro.  Since crude extracts were used in 
this study, further experiments need to be done 
in order to isolate the active compound or 
compounds and determine their toxicity in their 
pure form.  Non-toxic compounds may serve as 
templates in production of new antibiotics.  
These compounds may also be used to make teas 
and lotions.    
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